Streetbeat News

Stock Prices

SKIN

BeautyHealth has announced plans to initiate a stock repurchase program, following a recent authorization to repurchase $100M worth of shares.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 12:01 pm

SMAR

Analysts have provided various ratings for Smartsheet (NYSE:SMAR) within the last quarter, with 3 bullish, 3 somewhat bullish, and 2 indifferent. The average 12-month price target for Smartsheet has increased by 6.44% from the previous average price target of $50.50 to $53.75.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:01 pm

VTR

In the last quarter, Ventas (NYSE:VTR) received various analyst ratings, with 2 being bullish, 3 somewhat bullish, and 4 indifferent. Over the past 3 months, 9 analysts have offered 12-month price targets for Ventas, with an average price target of $50.67, a decrease of 0.65% from the previous average price target of $51.00.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:01 pm

SBUX

In the last quarter, Starbucks (NASDAQ:SBUX) received 1 bullish, 3 somewhat bullish, and 10 indifferent ratings from analysts. The company's average 12-month price target is $113.64, representing a 1.34% decrease from the previous average price target of $115.18.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:01 pm

DPZ

In the last quarter, 36 analysts have given ratings on Domino's Pizza (NYSE:DPZ). The average price target is $404.25, indicating an upside from the current price of $382.83. The average price target has increased by 8.87% over the past month.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:00 pm

SITC

In the last quarter, SITE Centers (NYSE:SITC) received one somewhat bullish rating and three indifferent ratings from analysts. The company's average 12-month price target is $14.5, which has increased by 7.41% over the past month.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:00 pm

RVNC

Analysts have provided bullish ratings for Revance Therapeutics (NASDAQ:RVNC) in the last quarter. The average price target is $34.33, implying an upside from the current price of $13.81. However, this represents an 8.04% decrease from the previous average price target of $37.33.

Portfolio Pulse from Benzinga Insights

September 20, 2023 | 12:00 pm

ENVB

EYEN

PRCH

Insiders at Eyenovia, Inc. (EYEN), Enveric Biosciences, Inc. (ENVB), and Porch Group, Inc. (PRCH) have recently acquired shares, indicating their confidence in the companies' prospects. EYEN's CEO bought 2,537 shares at an average price of $1.70, following a $12 million registered direct offering. ENVB's Director purchased 1,000 shares at an average price of $2.14, after the company filed a provisional patent application for AI-based computational methods. PRCH's Director, CEO, Chairman, and Founder acquired 86,373 shares at an average price of $0.83, despite the company posting a wider-than-expected quarterly loss.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 11:58 am

NIO

Nio, Inc. (NYSE:NIO) shares were advancing in premarket trading on Wednesday, following a 17.07% plunge in the previous session. The company announced plans to offer $1 billion in convertible senior notes in two parts, with the proceeds to be used for repurchasing existing debt securities and strengthening its balance sheet. Despite the capital raise not involving the sale of additional shares, the stock was hammered on Tuesday. European registration data showed Nio sold 46 European cars in September.

Portfolio Pulse from Shanthi Rexaline

September 20, 2023 | 11:51 am

SPRY

ARS Pharma's shares are trading lower following the FDA's Complete Response Letter for the company's neffy epinephrine nasal spray, requesting additional study.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:51 am